Table of Content
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2. MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.11 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3. PREMIUM INSIGHTS
3.1 PESTEL ANALYSIS
3.2 PORTER’S FIVE FORCES MODEL
4. INDUSTRY INSIGHTS
4.1 MICRO AND MACRO ECONOMIC FACTORS
4.2 PENETRATION AND GROWTH PROSPECT MAPPING
4.3 KEY PRICING STRATEGIES
4.4 INTERVIEWS WITH SPECIALIST
4.5 ANALYIS AND RECOMMENDATION
5. INTELLECTUAL PROPERTY (IP) PORTFOLIO
5.1 PATENT QUALITY AND STRENGTH
5.2 PATENT FAMILIES
5.3 LICENSING AND COLLABORATIONS
5.4 COMPETITIVE LANDSCAPE
5.5 IP STRATEGY AND MANAGEMENT
5.6 OTHER
6. COST ANALYSIS BREAKDOWN
7. TECHNONLOGY ROADMAP
8. INNOVATION TRACKER AND STRATEGIC ANALYSIS
8.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
8.1.1 JOINT VENTURES
8.1.2 MERGERS AND ACQUISITIONS
8.1.3 LICENSING AND PARTNERSHIP
8.1.4 TECHNOLOGY COLLABORATIONS
8.1.5 STRATEGIC DIVESTMENTS
8.2 NUMBER OF PRODUCTS IN DEVELOPMENT
8.3 STAGE OF DEVELOPMENT
8.4 TIMELINES AND MILESTONES
8.5 INNOVATION STRATEGIES AND METHODOLOGIES
8.6 RISK ASSESSMENT AND MITIGATION
8.7 FUTURE OUTLOOK
9. REGULATORY COMPLIANCE
9.1 REGULATORY AUTHORITIES
9.2 REGULATORY CLASSIFICATIONS
9.3 REGULATORY SUBMISSIONS
9.4 INTERNATIONAL HARMONIZATION
9.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
9.6 REGULATORY CHALLENGES AND STRATEGIES
10. REIMBURSEMENT FRAMEWORK
11. OPPUTUNITY MAP ANALYSIS
12. VALUE CHAIN ANALYSIS
13. HEALTHCARE ECONOMY
13.1 HEALTHCARE EXPENDITURE
13.2 CAPITAL EXPENDITURE
13.3 CAPEX TRENDS
13.4 CAPEX ALLOCATION
13.5 FUNDING SOURCES
13.6 INDUSTRY BENCHMARKS
13.7 GDP RATION IN OVERALL GDP
13.8 HEALTHCARE SYSTEM STRUCTURE
13.9 GOVERNMENT POLICIES
13.10 ECONOMIC DEVELOPMENT
14. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, BY TYPE
14.1 OVERVIEW
14.2 REAL-TIME ACTION-TRIGGERED DEVICES
14.2.1 MEDICATION ADHERENCE DEVICES
14.2.1.1. SMART PILL BOTTLES
14.2.1.2. CONNECTED INHALERS
14.2.1.3. DIGITAL MEDICATION TRACKING SYSTEMS
14.2.2 REAL-TIME SYMPTOM MONITORING DEVICES
14.2.2.1. HEART RATE MONITORS
14.2.2.2. WEARABLE OXYGEN SATURATION MONITORS
14.2.2.3. PAIN AND FATIGUE LEVEL TRACKERS
14.2.3 PATIENT-REPORTED OUTCOME (PRO) DEVICES
14.2.3.1. SMART DEVICES TRIGGERING SYMPTOM DIARIES
14.2.3.2. DEVICES FOR MOOD AND COGNITIVE ASSESSMENTS
14.2.4 WEARABLES FOR ACTIVITY MONITORING
14.2.4.1. ACCELEROMETERS FOR TRIGGERING EXERCISE/REST LOGS
14.2.4.2. WEARABLE FITNESS TRACKERS FOR PHYSICAL ACTIVITY ASSESSMENTS
14.3 CONTINUOUS DATA COLLECTION DEVICES
14.3.1 CONTINUOUS GLUCOSE MONITORS (CGMS)
14.3.2 WEARABLE ECG/EEG MONITORS
14.3.2.1. CONTINUOUS HEART RATE/ECG MONITORS
14.3.2.2. BRAIN ACTIVITY AND SLEEP MONITORING
14.3.3 SMARTWATCHES AND FITNESS TRACKERS
14.3.3.1. HEART RATE AND SLEEP PATTERN TRACKERS
14.3.3.2. ACTIVITY AND STEP COUNTERS
14.3.3.3. CALORIE EXPENDITURE MONITORING
14.3.4 BIOSENSORS FOR REMOTE MONITORING
14.3.4.1. BLOOD PRESSURE SENSORS
14.3.4.2. TEMPERATURE AND RESPIRATORY RATE MONITORS
14.3.4.3. SPO2 MONITORS
15. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, BY APPLICATION
15.1 OVERVIEW
15.2 DIABETES MANAGEMENT
15.3 HEART RATE
15.4 BLOOD OXYGEN
15.5 CHRONIC DISEASE MANAGEMENT
15.6 FITNESS AND WELLNESS MONITORING
15.7 REAL-TIME HEALTH MONITORING
15.8 EMERGENCY CARE
15.9 OTHERS
16. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, BY ERGONOMICS
16.1 OVERVIEW
16.2 PATCHES
16.3 RINGS
16.4 BANDS AND BRACELETS
16.5 SMART CLOTHING
16.6 IMPLANTABLE AND BIOCOMPATIBLE SENSORS
16.7 FOOT SENSORS
16.8 OTHERS
17. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, BY SENSOR TYPE
17.1 OVERVIEW
17.2 OPTICAL SENSORS
17.3 PIEZOELECTRIC SENSORS
17.4 TEMPERATURE SENSORS
17.5 MOTION SENSORS
17.6 STRAIN SENSORS
17.7 BIOCHEMICAL SENSORS
18. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, BY CONNECTIVITY
18.1 OVERVIEW
18.2 WIRED
18.3 WIRELESS
18.3.1 BLUETOOTH
18.3.2 WI-FI
18.3.3 NFC
18.3.4 CELLULAR
18.3.5 OTHERS
19. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, BY END USER
19.1 OVERVIEW
19.2 HOSPITALS AND CLINICS
19.3 BIOPHARMACEUTICAL COMPANIES
19.3.1 PHARMACEUTICAL COMPANIES
19.3.2 BIOTECHNOLOGY COMPANIES
19.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
19.5 OTHERS
20. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, BY DISTRIBUTION CHANNEL
20.1 OVERVIEW
20.2 RETAIL SALES
20.2.1 OFFLINE
20.2.2 ONLINE
20.3 OTHERS
21. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, SWOT AND DBMR ANALYSIS
22. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, BY REGION
GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
22.1 NORTH AMERICA
22.1.1 U.S.
22.1.2 CANADA
22.1.3 MEXICO
22.2 EUROPE
22.2.1 GERMANY
22.2.2 FRANCE
22.2.3 U.K.
22.2.4 ITALY
22.2.5 SPAIN
22.2.6 RUSSIA
22.2.7 TURKEY
22.2.8 BELGIUM
22.2.9 NETHERLANDS
22.2.10 SWITZERLAND
22.2.11 REST OF EUROPE
22.3 ASIA-PACIFIC
22.3.1 JAPAN
22.3.2 CHINA
22.3.3 SOUTH KOREA
22.3.4 INDIA
22.3.5 AUSTRALIA
22.3.6 SINGAPORE
22.3.7 THAILAND
22.3.8 MALAYSIA
22.3.9 INDONESIA
22.3.10 PHILIPPINES
22.3.11 REST OF ASIA-PACIFIC
22.4 SOUTH AMERICA
22.4.1 BRAZIL
22.4.2 ARGENTINA
22.4.3 REST OF SOUTH AMERICA
22.5 MIDDLE EAST AND AFRICA
22.5.1 SOUTH AFRICA
22.5.2 SAUDI ARABIA
22.5.3 UAE
22.5.4 EGYPT
22.5.5 ISRAEL
22.5.6 REST OF MIDDLE EAST AND AFRICA
22.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
23. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, COMPANY LANDSCAPE
23.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
23.2 COMPANY SHARE ANALYSIS: EUROPE
23.3 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
23.4 MERGERS & ACQUISITIONS
23.5 NEW PRODUCT DEVELOPMENT & APPROVALS
23.6 EXPANSIONS
23.7 REGULATORY CHANGES
23.8 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
24. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, SWOT AND DBMR ANALYSIS
25. GLOBAL WEARABLE BIOSENSORS IN CLINICAL TRIALS MARKET, COMPANY PROFILE
25.1 ABBOTT
25.1.1 COMPANY OVERVIEW
25.1.2 REVENUE ANALYSIS
25.1.3 GEOGRAPHIC PRESENCE
25.1.4 PRODUCT PORTFOLIO
25.1.5 RECENT DEVELOPMENTS
25.2 MEDTRONIC
25.2.1 COMPANY OVERVIEW
25.2.2 REVENUE ANALYSIS
25.2.3 GEOGRAPHIC PRESENCE
25.2.4 PRODUCT PORTFOLIO
25.2.5 RECENT DEVELOPMENTS
25.3 KONINKLIJKE PHILIPS N.V.
25.3.1 COMPANY OVERVIEW
25.3.2 REVENUE ANALYSIS
25.3.3 GEOGRAPHIC PRESENCE
25.3.4 PRODUCT PORTFOLIO
25.3.5 RECENT DEVELOPMENTS
25.4 BIOLINQ, INC.
25.4.1 COMPANY OVERVIEW
25.4.2 REVENUE ANALYSIS
25.4.3 GEOGRAPHIC PRESENCE
25.4.4 PRODUCT PORTFOLIO
25.4.5 RECENT DEVELOPMENTS
25.5 SENSIRION AG
25.5.1 COMPANY OVERVIEW
25.5.2 REVENUE ANALYSIS
25.5.3 GEOGRAPHIC PRESENCE
25.5.4 PRODUCT PORTFOLIO
25.5.5 RECENT DEVELOPMENTS
25.6 VITALCONNECT, INC.
25.6.1 COMPANY OVERVIEW
25.6.2 REVENUE ANALYSIS
25.6.3 GEOGRAPHIC PRESENCE
25.6.4 PRODUCT PORTFOLIO
25.6.5 RECENT DEVELOPMENTS
25.7 LIFESIGNALS
25.7.1 COMPANY OVERVIEW
25.7.2 REVENUE ANALYSIS
25.7.3 GEOGRAPHIC PRESENCE
25.7.4 PRODUCT PORTFOLIO
25.7.5 RECENT DEVELOPMENTS
25.8 APPLE INC.
25.8.1 COMPANY OVERVIEW
25.8.2 REVENUE ANALYSIS
25.8.3 GEOGRAPHIC PRESENCE
25.8.4 PRODUCT PORTFOLIO
25.8.5 RECENT DEVELOPMENTS
25.9 GARMIN LTD.
25.9.1 COMPANY OVERVIEW
25.9.2 REVENUE ANALYSIS
25.9.3 GEOGRAPHIC PRESENCE
25.9.4 PRODUCT PORTFOLIO
25.9.5 RECENT DEVELOPMENTS
25.10 OMRON CORPORATION
25.10.1 COMPANY OVERVIEW
25.10.2 REVENUE ANALYSIS
25.10.3 GEOGRAPHIC PRESENCE
25.10.4 PRODUCT PORTFOLIO
25.10.5 RECENT DEVELOPMENTS
25.11 SAMSUNG ELECTRONICS CO., LTD.
25.11.1 COMPANY OVERVIEW
25.11.2 REVENUE ANALYSIS
25.11.3 GEOGRAPHIC PRESENCE
25.11.4 PRODUCT PORTFOLIO
25.11.5 RECENT DEVELOPMENTS
25.12 HONEYWELL INTERNATIONAL INC.
25.12.1 COMPANY OVERVIEW
25.12.2 REVENUE ANALYSIS
25.12.3 GEOGRAPHIC PRESENCE
25.12.4 PRODUCT PORTFOLIO
25.12.5 RECENT DEVELOPMENTS
25.13 TE CONNECTIVITY
25.13.1 COMPANY OVERVIEW
25.13.2 REVENUE ANALYSIS
25.13.3 GEOGRAPHIC PRESENCE
25.13.4 PRODUCT PORTFOLIO
25.13.5 RECENT DEVELOPMENTS
25.14 INFINEON TECHNOLOGIES AG
25.14.1 COMPANY OVERVIEW
25.14.2 REVENUE ANALYSIS
25.14.3 GEOGRAPHIC PRESENCE
25.14.4 PRODUCT PORTFOLIO
25.14.5 RECENT DEVELOPMENTS
25.15 ZIMMER & PEACOCK AS
25.15.1 COMPANY OVERVIEW
25.15.2 REVENUE ANALYSIS
25.15.3 GEOGRAPHIC PRESENCE
25.15.4 PRODUCT PORTFOLIO
25.15.5 RECENT DEVELOPMENTS
25.16 BOSCH SENSORTEC GMBH
25.16.1 COMPANY OVERVIEW
25.16.2 REVENUE ANALYSIS
25.16.3 GEOGRAPHIC PRESENCE
25.16.4 PRODUCT PORTFOLIO
25.16.5 RECENT DEVELOPMENTS
25.17 PANASONIC CORPORATION
25.17.1 COMPANY OVERVIEW
25.17.2 REVENUE ANALYSIS
25.17.3 GEOGRAPHIC PRESENCE
25.17.4 PRODUCT PORTFOLIO
25.17.5 RECENT DEVELOPMENTS
25.18 EPSON
25.18.1 COMPANY OVERVIEW
25.18.2 REVENUE ANALYSIS
25.18.3 GEOGRAPHIC PRESENCE
25.18.4 PRODUCT PORTFOLIO
25.18.5 RECENT DEVELOPMENTS
25.19 AMS-OSRAM AG
25.19.1 COMPANY OVERVIEW
25.19.2 REVENUE ANALYSIS
25.19.3 GEOGRAPHIC PRESENCE
25.19.4 PRODUCT PORTFOLIO
25.19.5 RECENT DEVELOPMENTS
25.20 PHILLIPS
25.20.1 COMPANY OVERVIEW
25.20.2 REVENUE ANALYSIS
25.20.3 GEOGRAPHIC PRESENCE
25.20.4 PRODUCT PORTFOLIO
25.20.5 RECENT DEVELOPMENTS
25.21 NXP SEMICONDUCTORS
25.21.1 COMPANY OVERVIEW
25.21.2 REVENUE ANALYSIS
25.21.3 GEOGRAPHIC PRESENCE
25.21.4 PRODUCT PORTFOLIO
25.21.5 RECENT DEVELOPMENTS
25.22 INVENSENSE
25.22.1 COMPANY OVERVIEW
25.22.2 REVENUE ANALYSIS
25.22.3 GEOGRAPHIC PRESENCE
25.22.4 PRODUCT PORTFOLIO
25.22.5 RECENT DEVELOPMENTS
25.23 BUTLER TECHNOLOGIES
25.23.1 COMPANY OVERVIEW
25.23.2 REVENUE ANALYSIS
25.23.3 GEOGRAPHIC PRESENCE
25.23.4 PRODUCT PORTFOLIO
25.23.5 RECENT DEVELOPMENTS
25.24 PKVITALITY
25.24.1 COMPANY OVERVIEW
25.24.2 REVENUE ANALYSIS
25.24.3 GEOGRAPHIC PRESENCE
25.24.4 PRODUCT PORTFOLIO
25.24.5 RECENT DEVELOPMENTS
25.25 NEUROSKY
25.25.1 COMPANY OVERVIEW
25.25.2 REVENUE ANALYSIS
25.25.3 GEOGRAPHIC PRESENCE
25.25.4 PRODUCT PORTFOLIO
25.25.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
26. QUESTIONNAIRE
27. RELATED REPORT
28. CONCLUSION
29. ABOUT DATA BRIDGE MARKET RESEARCH
